advertisement
11.14 Investigational drugs; pharmacological experiments (15)
Showing records 1 to 15
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments24941 Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma
Yang H; Hirooka K; Fukuda K; Shiraga F
Investigative Ophthalmology and Visual Science 2009; 50: 5800-5804
24835 Ocular pharmacokinetics and hypotensive activity of PF-04475270, an EP4 prostaglandin agonist in preclinical models
Prasanna G; Fortner J; Xiang C; Zhang E; Carreiro S; Anderson S; Sartnurak S; Wu G; Gukasyan H; Niesman M
Experimental Eye Research 2009; 89: 608-617
24950 Effect of systemic moxaverine on ocular blood flow in humans
Resch H; Weigert G; Karl K; Pemp B; Garhofer G; Schmetterer L
Acta Ophthalmologica 2009; 87: 731-735
24626 Evaluation of a new lead for acetylcholinesterase inhibition
Khorana N; Markmee S; Ingkaninan K; Ruchirawat S; Kitbunnadaj R; Pullagurla MR
Medicinal Chemistry Research 2009; 18: 231-241
24832 Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine
Fitzgerald M; Payne SC; Bartlett CA; Evill L; Harvey AR; Dunlop SA
Investigative Ophthalmology and Visual Science 2009; 50: 5456-5462
24522 Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells
Koriyama Y; Ohno M; Kimura T; Kato S
Brain Research 2009; 1296: 187-195
24669 Endocannabinoid system: Emerging role from neurodevelopment to neurodegeneration
Basavarajappa BS; Nixon RA; Arancio O
Mini Reviews in Medicinal Chemistry 2009; 9: 448-462
24715 Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications
Galal AM; Slade D; Gul W; El-Alfy AT; Ferreira D; Elsohly MA
Recent Patents on CNS Drug Discovery 2009; 4: 112-136
24538 Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma
Harrison BA; Whitlock NA; Voronkov MV; Almstead ZY; Gu K-J; Mabon R; Gardyan M; Hamman BD; Allen J; Gopinathan S
Journal of Medicinal Chemistry 2009; 52: 6515-6518
24756 Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects
Garhofer G; Resch H; Wolzt M; Schmetterer L
Basic and Clinical Pharmacology and Toxicology 2009; 105 42
24551 Intraocular pressure-lowering activity of topical application of Aegle marmelos fruit extract in experimental animal models
Agarwal R; Gupta SK; Srivastava S; Saxena R; Agrawal SS
Ophthalmic Research 2009; 42: 112-116
24671 Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
Hahmann C; Schroeter T
Cellular and Molecular Life Sciences 2009; 1-7
24676 (alpha)-Luminol prevents decreases in glutamate, glutathione, and glutamine synthetase in the retinas of glaucomatous DBA/2J mice
Gionfriddo JR; Freeman KS; Groth A; Scofield VL; Alyahya K; Madl JE
Veterinary Ophthalmology 2009; 12: 325-332
24770 BMP-7: Therapeutic target for ocular fibrotic disorders
Wang J-Y; Han G-g; Wang J; Mei H-F; Yang A-H
Bioscience Hypotheses 2009; 2: 413-416
24755 Mitochondria-targeted rechargeable antioxidant SkQ1 prevents senescence in mammals
Skulachev V
FEBS Journal 2009; 276 35-36
